Skip to main content

Pressure Ulcer

1
Pipeline Programs
15
Companies
16
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

14 companies ranked by most advanced pipeline stage

Precisio Biotix Therapeutics
1 program
1
Bacteriophage-loaded Microcapsule SprayPhase 1/21 trial
Active Trials
NCT04815798Unknown69Est. Dec 2023
Abbott
AbbottABBOTT PARK, IL
1 program
AboundN/A1 trial
Active Trials
NCT01090076Completed26Est. Sep 2011
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
Biophysical and biochemical skin assessmentN/A1 trial
Active Trials
NCT06420102Completed50Est. Jul 2023
Next Science
Next ScienceAustralia - Sydney
1 program
BlastX with negative pressure therapyN/A1 trial
Active Trials
NCT04265170Completed20Est. Feb 2022
Century Therapeutics
Century TherapeuticsPHILADELPHIA, PA
1 program
ForeSite PT™ systemN/A1 trial
Active Trials
NCT02325388Completed678Est. May 2018
B. Braun
B. BraunGermany - Melsungen
1 program
LinoveraN/A3 trials
Active Trials
NCT06183086Unknown95Est. Dec 2024
NCT05763654Unknown164Est. Dec 2023
NCT02526862Completed152Est. Aug 2013
Masimo
MasimoIRVINE, CA
1 program
Masimo Centroid SystemN/A1 trial
Active Trials
NCT03121144Completed34Est. Mar 2019
Pharmamel
PharmamelSpain - Granada
1 program
MelatoninN/A1 trial
Active Trials
NCT06421454Not Yet Recruiting50Est. Nov 2025
Leaf Healthcare
Leaf HealthcareCA - Pleasanton
1 program
Optimal TurningN/A1 trial
Active Trials
NCT02533726Completed1,312Est. Feb 2016
Innovation Pharmaceuticals
1 program
Parafricta booteesN/A1 trial
Active Trials
NCT04023981Terminated31Est. Apr 2018
Organogenesis
OrganogenesisCANTON, MA
1 program
PuraPly™ Antimicrobial Wound MatrixN/A1 trial
Active Trials
NCT03070938Completed100Est. Oct 2017
Precision BioSciences
1 program
Silk-Like LinensN/A1 trial
Active Trials
NCT02925741Completed3,343Est. Mar 2015
Magellan
MagellanWALLACE, ID
1 program
Skin IQ™ MCM CoverletN/A1 trial
Active Trials
NCT02363842Unknown160Est. Feb 2016
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Skin Protection Wheelchair Seat CushionN/A1 trial
Active Trials
NCT00178126Completed232Est. Oct 2008

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
B. BraunLinovera
Precisio Biotix TherapeuticsBacteriophage-loaded Microcapsule Spray
PharmamelMelatonin
B. BraunLinovera
B. BraunLinovera
UNION therapeuticsBiophysical and biochemical skin assessment
Next ScienceBlastX with negative pressure therapy
Innovation PharmaceuticalsParafricta bootees
MasimoMasimo Centroid System
OrganogenesisPuraPly™ Antimicrobial Wound Matrix
Leaf HealthcareOptimal Turning
MagellanSkin IQ™ MCM Coverlet
Century TherapeuticsForeSite PT™ system
Precision BioSciencesSilk-Like Linens
AbbottAbound

Showing 15 of 16 trials with date data

Clinical Trials (16)

Total enrollment: 6,516 patients across 16 trials

NCT02526862B. BraunLinovera

Prevention of Pressure Ulcers in Patients Under Non-Invasive Mechanical Ventilation

Start: Feb 2012Est. completion: Aug 2013152 patients
Phase 4Completed
NCT04815798Precisio Biotix TherapeuticsBacteriophage-loaded Microcapsule Spray

Phage Therapy for the Prevention and Treatment of Pressure Ulcers.

Start: Jan 2022Est. completion: Dec 202369 patients
Phase 1/2Unknown
NCT06421454PharmamelMelatonin

Clinical Trial for the Evaluation of Melatonin in the Treatment of Pressure Ulcers

Start: Sep 2024Est. completion: Nov 202550 patients
N/ANot Yet Recruiting
NCT06183086B. BraunLinovera

PMCF Study on the Safety of Linovera® for the Treatment of Category-I Pressure Ulcers/Injuries

Start: Nov 2023Est. completion: Dec 202495 patients
N/AUnknown
NCT05763654B. BraunLinovera

PMCF Study on the Safety of Linovera Emulsion for the Prevention of Cat-1 Pressure Ulcers, Vascular and DFU

Start: Dec 2022Est. completion: Dec 2023164 patients
N/AUnknown
NCT06420102UNION therapeuticsBiophysical and biochemical skin assessment

Detecting Changes in Skin Status Over the Site of a Stage 1 Pressure Ulcer Using Biophysical Sensors and Biomarkers

Start: Nov 2021Est. completion: Jul 202350 patients
N/ACompleted
NCT04265170Next ScienceBlastX with negative pressure therapy

Evaluating Blast-X® in Combination With Negative Pressure Wound Therapy

Start: Oct 2019Est. completion: Feb 202220 patients
N/ACompleted
NCT04023981Innovation PharmaceuticalsParafricta bootees

Parafricta Bootees vs UK Standard Care to Prevent Heel Pressure Ulcers

Start: Oct 2017Est. completion: Apr 201831 patients
N/ATerminated
NCT03121144MasimoMasimo Centroid System

Usability Validation of Patient Monitoring Device for Pressure Injury Prevention and Fall Detection

Start: Mar 2017Est. completion: Mar 201934 patients
N/ACompleted
NCT03070938OrganogenesisPuraPly™ Antimicrobial Wound Matrix

PuraPly™ Antimicrobial Wound Matrix and Wound Management

Start: Nov 2016Est. completion: Oct 2017100 patients
N/ACompleted
NCT02533726Leaf HealthcareOptimal Turning

Optimal Patient Turning for Reducing Hospital Acquired Pressure Ulcers

Start: Aug 2015Est. completion: Feb 20161,312 patients
N/ACompleted
NCT02363842MagellanSkin IQ™ MCM Coverlet

Trial Comparing SOC +Skin IQ MCM vs SOC for Pressure Ulcer (PU)

Start: Apr 2015Est. completion: Feb 2016160 patients
N/AUnknown
NCT02325388Century TherapeuticsForeSite PT™ system

Pressure Sensing to Reduce the Risk of Pressure Ulcer Formation

Start: Dec 2014Est. completion: May 2018678 patients
N/ACompleted
NCT02925741Precision BioSciencesSilk-Like Linens

Silk-Like Bed Linens for Prevention of Unit-Acquired Ulcers

Start: Mar 2014Est. completion: Mar 20153,343 patients
N/ACompleted
NCT01090076AbbottAbound

The Use of Specialised Amino Acid Mixture in Pressure Ulcer Wound Healing Rates- A Placebo Controlled Trial

Start: Apr 2010Est. completion: Sep 201126 patients
N/ACompleted
NCT00178126Human BioSciencesSkin Protection Wheelchair Seat Cushion

An RCT on Preventing Pressure Ulcers With Wheelchair Seat Cushions

Start: Mar 2004Est. completion: Oct 2008232 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

15 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.